Feb 3 • 04:20 UTC 🇬🇷 Greece Naftemporiki

Stock Market - Lavipharm: The Rally Grows, the P/E Becomes Expensive

Lavipharm's stock continues its upward trend, approaching a 35% increase since the beginning of the year, while its valuation exceeds 220 million euros and the P/E ratio rises to 73x.

📡 Similar Coverage